切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2017, Vol. 06 ›› Issue (01) : 1 -5. doi: 10.3877/cma.j.issn.2095-3216.2017.01.001

所属专题: 文献

述评

先天·遗传·罕见肾脏病的精准诊断与干预措施
谢院生1,(), 陈香美1   
  1. 1. 100853 北京,解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 收稿日期:2016-12-28 出版日期:2017-02-28
  • 通信作者: 谢院生
  • 基金资助:
    国家重点研发计划(2016YFC901502); 国家重大科学研究计划(2011CB944004); 北京市自然科学基金(7152138); 国家自然科学基金(81473531)

Precise diagnosis and intervention measures for congenital, inherited, and rare kidney diseases

Yuansheng Xie1,(), Xiangmei Chen1   

  1. 1. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China
  • Received:2016-12-28 Published:2017-02-28
  • Corresponding author: Yuansheng Xie
  • About author:
    Corresponding author: Xie Yuansheng, Email:
引用本文:

谢院生, 陈香美. 先天·遗传·罕见肾脏病的精准诊断与干预措施[J]. 中华肾病研究电子杂志, 2017, 06(01): 1-5.

Yuansheng Xie, Xiangmei Chen. Precise diagnosis and intervention measures for congenital, inherited, and rare kidney diseases[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2017, 06(01): 1-5.

先天性和遗传性肾脏病是儿童尿毒症的主要原因、成人尿毒症的重要原因;罕见肾脏病种类繁多,大多数罕见病与遗传有关。环境因素、基因遗传因素以及表观遗传因素是引起先天·遗传·罕见肾脏病的重要原因。随着基因测序和生物信息分析技术的进步,过去很多诊断困难的先天·遗传·罕见肾脏病,通过临床、影像、分子病理和基因检测已逐渐能够精准诊断;通过早期的健康管理、对症支持治疗、针对分子发病机制的靶向治疗、基因或干细胞疗法以及中医中药治疗等,可以延缓疾病的进展。一些单基因遗传病,如常染色体显性遗传性多囊肾病和Alport综合征,通过体外受精、胚胎优选,可以预防其发生。为此,应重视先天·遗传·罕见肾脏病的基础和临床研究,力求精准诊断、有效治疗,阻断疾病的遗传,保护肾功能,改善患者的生活质量。

Congenital and inherited kidney diseases are the major causes of childhood uremia, and important causes of adult uremia, while there is a wide variety of rare kidney diseases, most of which are related to inheritance. Environmental factors, genetic factors, and epigenetic factors are important reasons to cause congenital-inherited-rare kidney diseases. With the progress of gene sequencing and bioinformatics analysis technology, many congenital-inherited-rare kidney diseases that were very difficult to diagnose in the past, have gradually been able to be precisely diagnosed by means of clinical, imaging, molecular pathological, and gene detection methods. Progression of these diseases can be delayed through early health management, symptomatic supporting treatment, molecular-mechanism-targeted therapy, gene or stem cell therapy and traditional chinese medicine. Some single-gene genetic diseases, such as autosomal dominant polycystic kidney disease and Alport syndrome, may be prevented from their occurrence through the in vitro fertilization and embryo selection techniques. Therefore, attention should be paid to the basic and clinical research of congenital-inherited-rare kidney diseases, striving for precise diagnosis and effective treatment, blocking disease inheritance, protecting renal function, and improving quality of life of patients.

[1]
Nicolaou N, Renkema KY, Bongers EM, et al. Genetic, environmental, and epigenetic factors involved in CAKUT [J]. Nat Rev Nephrol, 2015, 11(12): 720-731.
[2]
张雯,刘凯波,齐庆青,等.2008年-2014年北京地区先天性肾脏畸形发生状况分析[J]. 中国优生与遗传杂志,2015, 23(12): 74-77.
[3]
陈楠.重视遗传性肾脏疾病的筛查与诊治[J].中国实用内科杂志,2014, 34(3): 217-219.
[4]
Devuyst O, Knoers NV, Remuzzi G, et al. Rare inherited kidney diseases: challenges, opportunities, and perspectives [J]. Lancet, 2014, 383(9931): 1844-1859.
[5]
丁洁.遗传性肾脏疾病[J]. 医学继续教育,2006, 20(17): 49-52.
[6]
Chesnaye N, Bonthuis M, Schaefer F, et al. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry [J]. Pediatr Nephrol, 2014, 29(12): 2403-2410.
[7]
Parikh CR, McCall D, Engelman C, et al. Congenital renal agenesis: case-control analysis of birth characteristics [J]. Am J Kidney Dis, 2002, 39(4): 689-694.
[8]
Hsu CW, Yamamoto KT, Henry RK, et al. Prenatal risk factors for childhood CKD [J]. J Am Soc Nephrol, 2014, 25(9): 2105-2111.
[9]
齐焰,谢院生.视黄酸的结构、代谢、受体及其与器官发育的关系[J/CD].中华肾病研究电子杂志,2015,4(5): 257-260.
[10]
Reeders ST, Breuning MH, Davies KE, et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome[J]. Nature, 1985, 317(6037): 542-544.
[11]
The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 [J]. Cell, 1994, 77(6): 881-894.
[12]
Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome [J]. Science, 1990, 248(4960): 1224-1227.
[13]
Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications [J]. Nat Rev Genet, 2011, 13(2): 97-109.
[14]
Teh AL, Pan H, Chen L, et al. The effect of genotype and in utero environment on inter-individual variation in neonate DNA methylomes [J]. Genome Res, 2014, 24(7): 1064-1074.
[15]
Jin M, Zhu S, Hu P, et al. Genomic and epigenomic analyses of monozygotic twins discordant for congenital renal agenesis [J]. Am J Kidney Dis, 2014, 64(1): 119-122.
[16]
胡盼盼,金美玲,谢院生,等.马蹄肾的首诊表现、合并症及影像检查分析[J]. 中国中西医结合肾病杂志,2014, 15(4): 290-293.
[17]
Qi Y, Hu P, Xie Y, et al. Glomerular filtration rate measured by 99m Tc-DTPA renal dynamic imaging is significantly lower than that estimated by the CKD-EPI equation in horseshoe kidney patients [J]. Nephrology (Carlton), 2016, 21(6): 499-505.
[18]
王彩月,王立锋,伍建.遗传性疾病致病基因检测报告的解读[J/CD]. 中华肾病研究电子杂志,2017, 6(1): 9-13.
[19]
陈禹保,闫鹏程.生物信息学技术及其在肾脏病研究中的应用.[J/CD]. 中华肾病研究电子杂志,2017, 6(1): 14-19.
[20]
Sanna-Cherchi S, Kiryluk K, Burgess KE, et al. Copy-number disorders are a common cause of congenital kidney malformations [J]. Am J Hum Genet, 2012, 91(6): 987-997.
[21]
Jin M, Xie Y, Chen Z, et al. System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease [J]. Sci Rep, 2016, 6: 35945.
[22]
Weng PL, Sanna-Cherchi S, Hensle T, et al. A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13 [J]. J Am Soc Nephrol, 2009, 20(7): 1633-1640.
[23]
陈熳,谢院生.常染色体显性遗传性多囊肾病发病机制及治疗靶点的研究进展[J/CD]. 中华肾病研究电子杂志,2017, 6(1): 34-38.
[24]
Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease [J]. N Engl J Med, 2012, 367(25): 2407-2418.
[25]
丁洁,张琰琴.Alport综合征精准诊治进展[J /CD].中华肾病研究电子杂志,2016,5(2) : 53-55.
[26]
Heikkila P, Tibell A, Morita T, et al. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane [J]. Gene Ther, 2001, 8(11): 882-890.
[27]
Lin X, Suh JH, Go G, et al. Feasibility of repairing glomerular basement membrane defects in Alport syndrome [J]. J Am Soc Nephrol, 2014, 25(4): 687-692.
[28]
Byrne MC, Budisavljevic MN, Fan Z, et al. Renal transplant in patients with Alport′s syndrome [J]. Am J Kidney Dis, 2002, 39(4): 769-775.
[29]
薛澄,周晨辰,梅长林.多囊肾病网络数据库的研究进展[J/CD]. 中华肾病研究电子杂志,2017, 6(1): 31-33.
[30]
朱子璇,李明喜.特发性结节样肾小球硬化的诊断与治疗进展[J/CD].中华肾病研究电子杂志,2017, 6(1): 6-8.
[1] 杨丽, 钱桂生. 肺结节临床精准诊断的新理念[J]. 中华肺部疾病杂志(电子版), 2022, 15(01): 1-5.
[2] 田欣, 刘恩彬, 汝昆, 蔺亚妮. 髓系肿瘤精准诊断的检测体系和质控体系要略[J]. 中华临床实验室管理电子杂志, 2018, 06(02): 65-68.
[3] 杨策, 蒋建新, 杜娟, 王海燕, 高洁, 柳占立, 庄茁, 黄献聪, 马天, 王正国. 基于冲击伤诊治思考[J]. 中华诊断学电子杂志, 2016, 04(01): 10-12.
阅读次数
全文


摘要